195 related articles for article (PubMed ID: 38880655)
21. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
[TBL] [Abstract][Full Text] [Related]
22. Applications of machine learning in GPCR bioactive ligand discovery.
Jabeen A; Ranganathan S
Curr Opin Struct Biol; 2019 Apr; 55():66-76. PubMed ID: 31005679
[TBL] [Abstract][Full Text] [Related]
23. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
Bermudez M; Wolber G
Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
[TBL] [Abstract][Full Text] [Related]
24. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
[TBL] [Abstract][Full Text] [Related]
25. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
Cong X; Topin J; Golebiowski J
Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
[TBL] [Abstract][Full Text] [Related]
26. QSAR modeling of GPCR ligands: methodologies and examples of applications.
Tropsha A; Wang SX
Ernst Schering Found Symp Proc; 2006; (2):49-73. PubMed ID: 17703577
[TBL] [Abstract][Full Text] [Related]
27. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
Eglen RM; Bosse R; Reisine T
Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
[TBL] [Abstract][Full Text] [Related]
28. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
[TBL] [Abstract][Full Text] [Related]
29. G protein-coupled receptors--recent advances.
Latek D; Modzelewska A; Trzaskowski B; Palczewski K; Filipek S
Acta Biochim Pol; 2012; 59(4):515-29. PubMed ID: 23251911
[TBL] [Abstract][Full Text] [Related]
30. Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.
Li YY; Hou TJ; Goddard WA
Curr Med Chem; 2010; 17(12):1167-80. PubMed ID: 20158474
[TBL] [Abstract][Full Text] [Related]
31. GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update.
Okuno Y; Tamon A; Yabuuchi H; Niijima S; Minowa Y; Tonomura K; Kunimoto R; Feng C
Nucleic Acids Res; 2008 Jan; 36(Database issue):D907-12. PubMed ID: 17986454
[TBL] [Abstract][Full Text] [Related]
32. Structure determination of GPCRs: cryo-EM compared with X-ray crystallography.
García-Nafría J; Tate CG
Biochem Soc Trans; 2021 Nov; 49(5):2345-2355. PubMed ID: 34581758
[TBL] [Abstract][Full Text] [Related]
33. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.
Kortagere S; Welsh WJ
J Comput Aided Mol Des; 2006 Dec; 20(12):789-802. PubMed ID: 17054015
[TBL] [Abstract][Full Text] [Related]
34. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
Jaiteh M; Rodríguez-Espigares I; Selent J; Carlsson J
PLoS Comput Biol; 2020 Mar; 16(3):e1007680. PubMed ID: 32168319
[TBL] [Abstract][Full Text] [Related]
35. X-ray structure breakthroughs in the GPCR transmembrane region.
Topiol S; Sabio M
Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
[TBL] [Abstract][Full Text] [Related]
36. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
Filizola M; Weinstein H
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
[TBL] [Abstract][Full Text] [Related]
37. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
[TBL] [Abstract][Full Text] [Related]
38. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
Persechino M; Hedderich JB; Kolb P; Hilger D
Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
[TBL] [Abstract][Full Text] [Related]
39. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
Cross JB
Methods Mol Biol; 2018; 1705():233-264. PubMed ID: 29188566
[TBL] [Abstract][Full Text] [Related]
40. Integrating structural and mutagenesis data to elucidate GPCR ligand binding.
Munk C; Harpsøe K; Hauser AS; Isberg V; Gloriam DE
Curr Opin Pharmacol; 2016 Oct; 30():51-58. PubMed ID: 27475047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
